Gastrointestinal

Point-of-care rapid testing for gastrointestinal. OEM/ODM manufacturer.

Overview

Gastrointestinal infections (viral, bacterial, parasitic) and inflammatory bowel markers are common point-of-care needs.

Clinical Context

Gastrointestinal infections (viral, bacterial, parasitic) and inflammatory markers are common point-of-care needs.

Diagnostic Markers & Methods

Rotavirus/Adenovirus/Norovirus antigen · C. difficile (GDH + toxin) · Giardia/Cryptosporidium · Calprotectin/Lactoferrin (IBD) · FOB.

Antigen vs Antibody

Antigen tests detect active shedding; calprotectin/lactoferrin measure gut inflammation (IBD vs IBS).

Diagnostic Workflow

Diarrhea → antigen testing (rotavirus/adenovirus/norovirus, C. difficile GDH+toxin, parasites) → culture/molecular confirmation where needed.

Testing Window

Antigen detectable during active pathogen shedding.

Interpretation

Antigen detection indicates active shedding; calprotectin/lactoferrin support IBD vs functional distinction, not diagnosis alone.

False Negative / Positive Considerations

False negative: intermittent pathogen shedding. False positive: rare.

Confirmatory Testing

Culture or molecular (PCR) testing where required.

Testing Settings

Clinics and labs; C. difficile uses a two-step GDH+toxin algorithm.

Sources

IDSA C. difficile guideline; WHO diarrheal-disease guidance.

Progene's Take

Position: Bundle the gastro panel — rota/adeno/noro combo plus calprotectin — because primary-care buyers want one supplier for the whole GI screen.

Viral gastro combos cover the common pediatric pathogens in one device.
Calprotectin/lactoferrin add the IBD-vs-functional distinction that GPs ask for.
Low-MOQ, mixed-format catalog fill is the value for smaller distributors.

This is the buyer-advisor view of the technical team — editorial guidance, not a substitute for product IFU or local regulatory requirements.